Exploring how siblings of individuals with schizophrenia face unique life course challenges that increase their risk for depressive symptoms.
Exploring the role of 5-HT2A, 5-HTT and DISC1 genetic polymorphisms in first-episode schizophrenia patients and the future of personalized treatment.
Comprehensive overview of recent advances in understanding the neurobiology of schizophrenia, including dopamine and glutamate hypotheses, protein network models, biomarkers, and treatment approaches.
Explore how EEG technology is revolutionizing schizophrenia research by uncovering biological markers and developing innovative treatments.
Discover how NET, NT-3, and TrkC in T-cells may revolutionize schizophrenia diagnosis and treatment through peripheral biomarkers.
Exploring the surprising discovery that people with schizophrenia maintain precise working memories despite having reduced capacity to store multiple items.
Exploring cognitive dysmetria and brain disconnection in schizophrenia - how broken neural circuits explain the disorder's diverse symptoms.
Explore how Dr. Wayne Fenton revolutionized schizophrenia treatment through his groundbreaking MATRICS initiative and cognitive neuroscience research.
Exploring the evidence for neurotoxicity in prodromal and early schizophrenia through glutamate dysregulation, neuroinflammation, and blood-brain barrier dysfunction.
Exploring the complex genetic architecture of schizophrenia through cutting-edge genomic research and technologies.